Company: DERM
Filing Date: 2025-06-26
Form Type: 8-K
Source: 0001104659-25-063032
Chunk: 1

Company: Journey Medical Corp
Filing Date: 2025-06-26
Form: 8-K
Item: Item 5.07
Chunk 1
---
Item 5.07.      Submission of Matters to a Vote of Security Holders.  

On June 24, 2025, the Company held its 2025
Annual Meeting at 11:00 a. m. Eastern Time by means of an online virtual meeting platform. Stockholders representing 19,663,140 shares
of common stock, par value $0.0001 per share (the “ Common Stock”), of the Company and 6,000,000 shares of the Company’s
Class A Common Stock of the Company, or 85.04% of the 23,120,937 shares entitled to vote, were represented in person or by proxy,
constituting a quorum.

At the 2025 Annual Meeting, the following three
proposals were approved: (i) the election of six directors to hold office until the 2026 annual meeting of stockholders; (ii) the
ratification of the appointment of KPMG LLP as Journey’s independent registered public accounting firm for the year ending December 31,
2025; and (iii) the approval of the Fourth Amended and Restated Charter. The three proposals are described in detail in Journey’s
definitive proxy statement on Schedule 14A for the 2025 Annual Meeting filed with the SEC on April 29, 2025.

As of the April 25, 2025 record date for
the determination of the stockholders entitled to notice of, and to vote at, the 2025 Annual Meeting, 17,120,937 shares of the Company’s
Common Stock were outstanding and eligible to vote with an aggregate of 17,120,937 votes and 6,000,000 shares of the Company’s Class A
Common Stock were outstanding and eligible to vote with an aggregate of 18,840,000 votes, as determined in accordance with Article IV,
Section 3.2 of the Company’s Third Amended and Restated Certificate of Incorporation.

Proposal 1